Abound Wealth Management’s Select Medical SEM Stock Holding History

Abound Wealth Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6	Closed	-$98	–	1540
2026 Q1	$98	Hold	6	–	–	﹤0.01%	1420
2025 Q4	$90	Hold	6	–	–	﹤0.01%	1394
2025 Q3	$78	Hold	6	–	–	﹤0.01%	1324
2025 Q2	$92	Hold	6	–	–	﹤0.01%	1267
2025 Q1	$101	Hold	6	–	–	﹤0.01%	1230
2024 Q4	$114	Sell	6 -5	-45%	-$96	﹤0.01%	1201
2024 Q3	$210	Sell	11 -2	-15%	-$38	﹤0.01%	1137
2024 Q2	$246	Sell	13 -6	-32%	-$102	﹤0.01%	1042
2024 Q1	$302	Hold	19	–	–	﹤0.01%	1131
2023 Q4	$235	Hold	19	–	–	﹤0.01%	1250
2023 Q3	$253	Hold	19	–	–	﹤0.01%	1063
2023 Q2	$319	Buy	+19	New	+$294	﹤0.01%	1020

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Abound Wealth Management's SEM Position: Q2 2026 in Review

Abound Wealth Management sold out of Select Medical (SEM) in Q2 2026, closing a stake of 6 shares — an estimated $98 sold.

Abound Wealth Management first reported a position in SEM in Q2 2023 and held it in 12 quarters. The position peaked at $319 in Q2 2023. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

Abound Wealth Management reported no remaining Select Medical position as of Q2 2026 after selling out during the quarter.
Abound Wealth Management sold 6 Select Medical shares in Q2 2026, an estimated $98.
Abound Wealth Management first reported a position in Select Medical in Q2 2023 and held it in 12 quarters.
Abound Wealth Management's Select Medical position peaked at $319 in Q2 2023.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.